Tatva Chintan Pharma Chem (NSE:TATVA) Institutional Ownership: 5.74% (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:TATVA Tatva Chintan Pharma Chem Ltd NSE:TATVA
80 GF Score
Price ₹1,680.20
GF Value ₹1,524.25
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Tatva Chintan Pharma Chem Institutional Ownership?

Tatva Chintan Pharma Chem NSE:TATVA -0.92% 80 Institutional Ownership is 5.74% as of Sep. 09, 2026. GuruFocus rates NSE:TATVA with a GF Score™ of 80/100 and a GF Value™ of ₹1,524.25 (Fairly Valued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Tatva Chintan Pharma Chem's institutional ownership is 5.74%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Tatva Chintan Pharma Chem's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Tatva Chintan Pharma Chem's Float Percentage Of Total Shares Outstanding is 0.00%.

Tatva Chintan Pharma Chem Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Tatva Chintan Pharma Chem's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tatva Chintan Pharma Chem Institutional Ownership Chart

Tatva Chintan Pharma Chem Historical Data

The historical data trend for Tatva Chintan Pharma Chem can be seen below:

2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31 2026-08-31
Institutional Ownership 5.77 5.77 6.41 5.77 6.57 5.70 5.34 5.69 5.74 5.74
NSE:TATVA
80GF Score
Tatva Chintan Pharma Chem Ltd NSE:TATVA
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Tatva Chintan Pharma Chem Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 5.74% mean?
Tatva Chintan Pharma Chem (NSE:TATVA) has a Institutional Ownership of 5.74% as of Sep. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Tatva Chintan Pharma Chem and its competitors.
Is Tatva Chintan Pharma Chem's Institutional Ownership too high?
Tatva Chintan Pharma Chem's current Institutional Ownership is 5.74%. Overall, Tatva Chintan Pharma Chem has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Tatva Chintan Pharma Chem's Institutional Ownership compare to LIN and SHW?
Tatva Chintan Pharma Chem's Institutional Ownership of 5.74% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Chemicals company?
A good Institutional Ownership depends on the Chemicals industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Tatva Chintan Pharma Chem and its competitors. Tatva Chintan Pharma Chem's current Institutional Ownership is 5.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tatva Chintan Pharma Chem stock overvalued right now?
Based on GuruFocus' analysis, Tatva Chintan Pharma Chem (NSE:TATVA) is currently considered Fairly Valued. The stock's GF Value™ is ₹1,524.25, compared to a current price of ₹1,680.20 — trading 10.2% above its estimated fair value. The current Institutional Ownership is 5.74%. Tatva Chintan Pharma Chem's overall GF Score™ is 80/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Tatva Chintan Pharma Chem (NSE:TATVA), the current Institutional Ownership is 5.74% as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Tatva Chintan Pharma Chem (NSE:TATVA) Overvalued in 2026?

Based on GuruFocus' analysis, Tatva Chintan Pharma Chem stock appears to be overvalued. The current stock price of ₹1,680.20 is trading 10.2% above its estimated GF Value™ of ₹1,524.25. GuruFocus considers Tatva Chintan Pharma Chem to be Fairly Valued.

Key valuation signals for NSE:TATVA:

  • Institutional Ownership: 5.74%
  • GF Value™: ₹1,524.25 vs. price of ₹1,680.20 (10.2% above fair value)
  • GF Score™: 80/100 with 6 warning signs

No single metric tells the full story. See the NSE:TATVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tatva Chintan Pharma Chem Business Description

Other Exchanges 543321:India
Address Plot No. 353, Makarpura GIDC, Vadodara, GJ, IND, 390010
Tatva Chintan Pharma Chem Ltd is a specialty chemicals manufacturing company engaged in the manufacturing and selling of specialty chemicals, Pharma and Agro intermediates, Quaternary Compounds, and Quats. The company's product portfolio includes structure-directing agents, phase transfer catalysts, electrolyte salts for supercapacitor batteries, pharmaceutical and agrochemical intermediates and other specialty chemicals. The company sells its products in domestic as well as overseas markets, with the majority of revenue coming from overseas markets.
80GF Score

Get the complete analysis for NSE:TATVA

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,680.20
Price
₹1,524.25
GF Value